(Q59305031)
Statements
A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers (English)
Dominic Smethurst
Jim Growcott
Salvatore Febbraro
Helen Swaisland
D Ross Camidge
Nigel C Barrass
18 November 2006